Follow-up Management of the Paced Patient

  • Paul A. Levine
  • Dale M. Isaeff

The recommendation and subsequent implantation of a pacemaker constitutes a therapeutic prescription with the same long-term responsibility for the periodic assessment of the continued appropriateness of that therapy as with the prescription of any pharmacologic agent. The multiplicity of programmable options available in the modern pacemaker allows the physician to titrate the dose of pacing in a manner similar to the periodic adjustment of the dose of a medication. A prime example is renal failure which commonly requires a decrease in the dose of some medications necessitated by a reduction in renal clearance, this same condition may require an increase in the programmed output of the pacemaker if the patient is prone to hyperkalemia because of associated rises in the capture threshold. This chapter will review multiple aspects and techniques associated with the routine follow-up of the pacing system including biventricular systems.


Cardiac Resynchronization Therapy Pulse Generator Premature Ventricular Contraction Event Counter Pace System 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Griffin JC, Schuenemeyer TD, Pacemaker follow-up: An introduction and overview, Clin Prog Pacing Electrophysiol 1983; 1: 30–39.Google Scholar
  2. 2.
    Levine PA, (ed), Proceedings of the Policy Conference of the North American Society of Pacing and Electrophysiology on programmability and pacemaker follow-up programs, Clin Prog Pacing Electrophysiol 1984; 2: 145–191.Google Scholar
  3. 3.
    Castellanet MJ, Garza J, Shaner SP, Messenger JC, Telemetry of programmed and measured data in pacing system evaluation and follow-up, J Electrophysiol 1987; 1: 360–375.CrossRefGoogle Scholar
  4. 4.
    Levine PA, Love CJ, Pacemaker diagnostics and evaluation of pacing system malfunction. In Ellenbogen KA, Kay GN, Wilkoff BL, (eds) Clinical Cardiac Pacing (second edition). Philadelphia, W. B. Saunders Publishers, 1999; Chap. 30.Google Scholar
  5. 5.
    Stassen J, Ector H, de Geest H, The underlying heart rhythm in patients with an artificial pacemaker, PACE 1982; 5: 801–807.Google Scholar
  6. 6.
    Levine PA, Why programmability? Indications for and clinical utility of multiparameter programmable pacemakers. Sylmar, CA, Pacesetter Systems, Inc., 1981.Google Scholar
  7. 7.
    Strathmore NF, Mond HG, Noninvasive monitoring and testing of pacemaker function, PACE 1987; 10: 1359–1370.PubMedGoogle Scholar
  8. 8.
    Bernstein AD, Irwin ME, Parsonnet V, et al., Report of NASPE policy conference on antibradycardia pacemaker follow-up: Effectiveness, needs and resources, PACE 1994; 17: 1714–1729.PubMedGoogle Scholar
  9. 9.
    Levine PA, Schuller H, Lindgren A, Pacemaker ECG utilization of pulse generator telemetry–a benefit of space age technology. Siemens Pacesetter, Inc., Sylmar CA, 1988.Google Scholar
  10. 10.
    Kruse I, Markowitz T, Ryden L, Timing markers showing pacemaker behavior to aid in the follow-up of a physiologic pacemaker, PACE; 1983: 6: 801–805.PubMedGoogle Scholar
  11. 11.
    Olson W, McConnel M, Sah R, et al., Pacemaker diagnostic diagrams, PACE 1985; 8: 691–700.PubMedGoogle Scholar
  12. 12.
    Levine PA, Pacemaker diagnostic diagrams (letter), PACE 1986; 9: 250.PubMedGoogle Scholar
  13. 13.
    Furman S, The ECG interpretation channel (editorial), PACE 1990; 13: 225.Google Scholar
  14. 14.
    Olson WH, Goldreyer BA, Goldreyer BN, Computer-generated diagnostic diagrams for pacemaker rhythm analysis and pacing system evaluation, J. Electrocardiol 1987; 1; 376–387.Google Scholar
  15. 15.
    Levine PA, Sholder JA, Duncan JL, Clinical benefits of telemetered electrograms in assessment of DDD function, PACE 1984; 7: 1170–1177.PubMedGoogle Scholar
  16. 16.
    Clarke M, Allen A, Use of telemetered electrograms in the assessment of normal pacemaker function, J Electrophysiol 1987; 1: 388–395.CrossRefGoogle Scholar
  17. 17.
    Levine PA, The complementary role of electrogram, event marker and measured data telemetry in the assessment of pacing system function, J Electrophysiol 1987; 1: 404–416.CrossRefGoogle Scholar
  18. 18.
    Gladstone PJ, Duxbury GB, Berman ND, Arrhythmia diagnosis by electrogram telemetry: Involvement of dual chamber pacemaker, Chest 1987; 91: 115–116.CrossRefPubMedGoogle Scholar
  19. 19.
    Marco DD, Gallagher D, Noninvasive measurement of retrograde conduction times in pacemaker patients, PACE 1988; 11: 1673–1678.PubMedGoogle Scholar
  20. 20.
    Hughes HC, Furman S, Brownlee RR, Del Marco C, Simultaneous atrial and ventricular electrogram transmission via a specialized single-lead system, PACE 1984; 7: 1195–1201.PubMedGoogle Scholar
  21. 21.
    Feuer J, Florio J, Shandling AH, Alternate methods for the determination of atrial capture thresholds utilizing the telemetered intracardiac electrogram, PACE 1990; 13: 1254–1260.PubMedGoogle Scholar
  22. 22.
    Sarmiento JJ, Clinical utility of telemetered intracardiac electrograms in diagnosing a design dependent lead malfunction, PACE 1990; 13: 188–195.PubMedGoogle Scholar
  23. 23.
    Nalos PC, Nyitray W, Benefits of intracardiac electrograms and programmable sensing polarity in preventing pacemaker inhibition due to spurious screw-in lead signals, PACE 1990; 13: 1101–1104.PubMedGoogle Scholar
  24. 24.
    Gladstone PJ, Duxbury GB, Berman ND, Arrhythmia diagnosis by electrogram telemetry, involvement of dual chamber pacemakers, Chest 1987; 91: 115–116.CrossRefPubMedGoogle Scholar
  25. 25.
    Sanders R, Martin R, Frumin H, et al., Data storage and retrieval by implantable pacemakers for diagnostic purposes, PACE 1984: 7: 1228–1233.PubMedGoogle Scholar
  26. 26.
    Levine PA, Lindenberg BS, Diagnostic data: an aid to the follow-up and assessment of the pacing system, J Electrophysiol 1987; 1: 396–403.CrossRefGoogle Scholar
  27. 27.
    Hayes DL, Higano ST, Eisinger G, Utility of rate histograms in programming and follow-up of a DDDR pacemaker, Mayo Clin Proc 1989; 64: 495–502.PubMedGoogle Scholar
  28. 28.
    Levine PA, Sholder JA, Florio J, Obtaining maximal benefit from a DDDR pacing system: a reliable yet simple method for programming the sensor parameters of Synchrony. Siemens Pacesetter, Inc., Sylmar, CA, 1989.Google Scholar
  29. 29.
    Levine PA, Utility and clinical benefits of extensive event counter telemetry in the follow-up and management of the rate-modulated pacemaker patient. An introduction to PDx model 3037a software. Siemens Pacesetter, Inc., Sylmar CA, Feb 1992.Google Scholar
  30. 30.
    Newman D, Dorian P, Downar E, et al, Use of telemetry functions in the assessment of implanted antitachycardia device efficiency, Am J Cardiol 1992; 70: 616–622.CrossRefPubMedGoogle Scholar
  31. 31.
    Stangl K Sichart U, Wirtzfeld A, et al., Holter functions for the enhancement of the diagnostic and therapeutic capabilities of implantable pacemakers. Vitatext, Dieren, The Netherlands, Vitatron Medical 1987; 1–6.Google Scholar
  32. 32.
    Levine PA, Holter and pacemaker diagnostics. In Aubert AE, Ector H, Stroobandt R (eds), Cardiac Pacing and Electrophysiology, A Bridge to the 21st Century. Dordrecht, The Netherlands, Kluwer Academic Publishers, 1994; 309–324.Google Scholar
  33. 33.
    Novak M, Smola M, Kejrova E, Pacemaker built-in Holter counters match up to ambulatory Holter recordings. In Sethi KK (ed) Proceedings of the VIth Asian-Pacific Symposium on Cardiac Pacing and Electrophysiology, Bologna, Italy, Monduzzi Editore S.p.A., 1997; 61–64.Google Scholar
  34. 34.
    Limousin M, Gerous L, Nitzsche R, et al., Value of automatic processing and reliability of stored data in an implanted pacemaker, initial results in 59 patients, PACE 1997; 20: 2893–2898.PubMedGoogle Scholar
  35. 35.
    Machado C, Johnson D, Thacker JR, Duncan JL, Pacemaker patient-triggered event recordings, accuracy, utility and cost for the pacemaker follow-up clinic, PACE 1996; 19: 1813–1818.PubMedGoogle Scholar
  36. 36.
    Ohm OJ, Breivik K, Hammer EA, Hoff PI, Intraoperative electrical measurements during pacemaker implantation, Clin Prog Pacing Electrophysiol 1984; 2: 1–23.Google Scholar
  37. 37.
    Bernstein AD, Parsonnet V, Implications of constant-energy pacing, PACE 1983; 6: 1229–1233.PubMedGoogle Scholar
  38. 38.
    Irnich W, The chronaxie time and its practical importance, PACE 1980; 3: 292–301.PubMedGoogle Scholar
  39. 39.
    Stokes K, Bornzin G, The electrode-biointerface: Stimulation. In Barold SS (ed), Modern Cardiac Pacing. Armonk NY, Futura Publishing Co, 1985; 33–77.Google Scholar
  40. 40.
    Levine PA, Confirmation of atrial capture and determination of atrial capture thresholds in DDD pacing systems, Clin Prog Pacing Electrophysiol 1984; 2: 465–473.Google Scholar
  41. 41.
    Sowton E, Barr I, Physiologic changes in threshold, Ann NY Acad Sci, 1969; 167: 679–685.CrossRefPubMedGoogle Scholar
  42. 42.
    Preston TA, Fletcher RD, Lucchesi BR, Judge RD, Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers, Am Heart J 1967; 74: 235–242.CrossRefPubMedGoogle Scholar
  43. 43.
    Hayes DL, Effect of drugs and devices on permanent pacemakers, CARDIO 1991; 8: 70–75 (January).Google Scholar
  44. 44.
    Danilovic D, Ohm OH, Pacing threshold trends and variability in modern tined leads assessed using high resolution automatic measurements, conversion of pulse width into voltage thresholds, PACE 1999; 22: 567–587.PubMedGoogle Scholar
  45. 45.
    Syed J, Lau C, Nishimura S, Circadian and unexpected changes in stimulation threshold, PACE 1999; 22: 757.Google Scholar
  46. 46.
    Schuchert A, van Langen H, Michels K, et al., Present day pacemakers for pulse generator exchange: Is 3.5 Volts a sufficient nominal setting for the pulse amplitude? PACE 1996; 1824–1827.Google Scholar
  47. 47.
    Marco D, Pacemaker output settings for lowest current drain and maximum longevity, Reblampa 1995; 8: 159–162.Google Scholar
  48. 48.
    Crossley GH, Gayle D, Simmons TW, et al., Reprogramming pacemakers enhances longevity and is cost-effective, Circulation 1996; 94 (Suppl II): 245–247.Google Scholar
  49. 49.
    Furman S, Hurzeler P, de Caprio V, Cardiac pacing and pacemakers III. Sensing the cardiac electrogram, Am Heart J 1977; 93: 794–801.CrossRefPubMedGoogle Scholar
  50. 50.
    Clarke M, Liu B, Schuller H, et al., Automatic adjustment of pacemaker stimulation output correlated with continuously monitored capture thresholds, a multicenter study, PACE 1998; 21: 1567–1575.PubMedGoogle Scholar
  51. 51.
    Cameron DA, Hale C, Cusimano RJ, et al., Dual chamber ventricular AutoCapture device, an initial experience, PACE 1999; 22: 854.Google Scholar
  52. 52.
    Nowak B, Kampmann C, Schmid FX, et al., Pacemaker therapy in premature children with high degree AV block, PACE 1998; 21: 2695–2698.PubMedGoogle Scholar
  53. 53.
    Breivik K, Ohm OJ, Engedal H, Long term comparison of unipolar and bipolar pacing and sensing using a new multiprogrammable pacemaker system, PACE 1983; 6: 592–600.PubMedGoogle Scholar
  54. 54.
    Ohm OJ, Demand failures occurring during permanent pacing in patients with serious heart disease, PACE 1980; 3: 44–55.PubMedGoogle Scholar
  55. 55.
    Griffin JC, Finke WL, Analysis of the endocardial electrogram morphology of isolated ventricular beats, PACE 1983; 6: 315.Google Scholar
  56. 56.
    Bricker JT, Ward KA, Zinner A, Gillette PC, Decrease in canine endocardial and epicardial electrogram voltage with exercise: Implications for pacemaker sensing, PACE 1988; 11: 460–464.PubMedGoogle Scholar
  57. 57.
    Frohlig G, Schwerdt H, Schieffer H, et al., Atrial signal variations and pacemaker malsensing during exercise: A study in the time and frequency domain, J Am Coll Cardiol 1988; 11: 806–813.PubMedCrossRefGoogle Scholar
  58. 58.
    Levine PA, Podrid PJ, Klein MD, Keefe J, Selznick L, Pacemaker sensing: Comparison of signal amplitudes determined by electrogram telemetry and noninvasively measured sensing thresholds, PACE 1989; 12: 1294.Google Scholar
  59. 59.
    Palma EC, Kedarnath V, Vankawalla V, et al., Effect of varying atrial sensitivity, AV interval, and detection algorithm on automatic mode switching, PACE 1996; 19: 1734–1739.Google Scholar
  60. 60.
    Brandt J, Fahraeus T, Schuller H, Far-field QRS complex sensing via the atrial pacemaker lead, I: Mechanism, consequences, differential diagnosis and countermeasures in AAI and VDD/DDD pacing, PACE 1988; 11: 1432–1438.PubMedGoogle Scholar
  61. 61.
    Secemsky SI, Hauser RG, Denes P, Edwards LM, Unipolar sensing abnormalities: incidence and clinical significance of skeletal muscle interference and undersensing in 228 patients, PACE 1982; 5: 10–19.PubMedGoogle Scholar
  62. 62.
    Levine PA, Caplan CH, Klein MD, Brodsky SJ, Ryan TJ, Myopotential inhibition of unipolar lithium pacemakers, Chest 1982; 82: 461–465.CrossRefPubMedGoogle Scholar
  63. 63.
    Gross JN, Platt S, Ritacco R, Andrews C, Furman S, The clinical relevance of electromyopotential oversensing in current unipolar devices, PACE 1992; 15: 2023–2027.PubMedGoogle Scholar
  64. 64.
    Technical Information Report–Systems used to forecast remaining pacemaker battery service life, Washington, DC, Association for the Advancement of Medical Instrumentation, 1998, Document # AAMI TIR No. 21–1998.Google Scholar
  65. 65.
    Jacobs DM, Fink AS, Miller RP, et al., Anatomical and morphological evaluation of pacemaker lead compression, PACE 1993; 16: 434–444.PubMedGoogle Scholar
  66. 66.
    Magney JE, Flynn DM, Parsons JA, et al., Anatomical mechanisms explaining damage to pacemaker leads, defibrillator leads and failure of central venous catheters adjacent to the sternoclavicular junction, PACE 1993; 16: 445–457.PubMedGoogle Scholar
  67. 67.
    Antonelli D, Rosenfeld T, Freedberg NA, et al., Insulation lead failure: Is it a matter of insulation coating, venous approach or both? PACE 1998; 21: 418–421.PubMedGoogle Scholar
  68. 68.
    Ben Zur UM, Platt SB, Gross JN, et al., Direct and telemetered lead impedance PACE 1994; 17: 2004–2007.PubMedGoogle Scholar
  69. 69.
    Danilovic D, Ohm OJ, Pacing impedance variability in tined steroid eluting leads, PACE 1998; 21: 1356–1363.PubMedGoogle Scholar
  70. 70.
    Sharif MN, Wyse DG, Rothschild JM Gillis AM, Changes in lead impedance over time predict lead failure, Am J Cardiol 1998; 82: 600–603.CrossRefPubMedGoogle Scholar
  71. 71.
    Siegmund JB, Wilson JH, Lattner SE, et al., Impedance of pacemaker leads: Correlation of different methods, PACE 1996; 19: 90–94.PubMedGoogle Scholar
  72. 72.
    Furman S, Pacemaker follow-up in Furman S, Hayes D, Holmes D (eds) A Practice of Cardiac Pacing. Armonk NY, Futura Publishing Company 1993; 571–603.Google Scholar
  73. 73.
    Vincent JA, Cavitt DL, Karpawich PP, Diagnostic and cost-effectiveness of telemonitoring the pediatric pacemaker patient, Pediatric Cardiol 1997; 18: 86–90.CrossRefGoogle Scholar
  74. 74.
    Dreifus LS, Zinberg A, Hurzeler P, et al., Transtelephonic monitoring of 25, 919 implanted pacemakers, PACE 1986; 9: 371–378.PubMedGoogle Scholar
  75. 75.
    Greendahl H, Pacemaker follow-up with prolonged intervals in the stable period of 1 to 5 years postimplant, PACE 1996; 19: 1219–1224.Google Scholar
  76. 76.
    Sweeesy MW, Erickson SL, Grago JA, et al., Analysis of the effectiveness of in-office and transtelephonic follow-up in terms of pacemaker system complications, PACE 1994; 17: 2001–2003.Google Scholar
  77. 77.
    Levine PA, Electrocardiography of bipolar single and dual-chamber pacing systems, Herzschrittmacher 1988; 8: 86–90.Google Scholar
  78. 78.
    Lesh MD, Langberg JJ, Griffin JC, et al., Pacemaker generator pseudomalfunction: an artifact of Holter monitoring, PACE 1991; 14: 854–857.PubMedGoogle Scholar
  79. 79.
    Van Gelder LM, Bracke FALE, El Gamal MIH, Fusion or confusion on Holter recordings, PACE 1991; 14: 760–763.PubMedGoogle Scholar
  80. 80.
    Engler RL, Goldberger AL, Bhargava V, Kapelusznik D, Pacemaker spike alternans: An artrifact of digital signal processing, PACE 1982; 5: 748–750.PubMedGoogle Scholar
  81. 81.
    Slack JP, Identification of recording artifact in a dual chamber (DDD) paced rhythm, clues from the electrocardiogram, Clin Prog Pacing Electrophysiol 1984; 2: 384–387.Google Scholar
  82. 82.
    Levine PA, Pacemaker pseudo-malfunction, PACE 1981; 4: 563–565.PubMedGoogle Scholar
  83. 83.
    Levine PA, Selznick L, Prospective management of the patient with retrograde ventriculo-atrial conduction, prevention and management of pacemaker mediated endless loop tachycardias. Sylmar, CA, Pacesetter, Inc., 1990.Google Scholar
  84. 84.
    Limousin M, Bonnet JL, A multi-centric study of 1816 endless loop tachycardia (ELT) responses, PACE 1990; 13: 555.Google Scholar
  85. 85.
    Oseran D, Ausubel K, Klementowicz P, et al., Spontaneous endless loop tachycardia, PACE 1986; 9: 379–381.PubMedGoogle Scholar
  86. 86.
    Levine PA, Postventricular atrial refractory periods and pacemaker mediated tachycardias, Clin Prog Pacing Electrophysiol 1983; 1: 394–401.Google Scholar
  87. 87.
    Famularo MA, Kennedy HL, Ambulatory electrocardiography in the assessment of pacemaker function, Am Heart J 1982; 104: 1086–1094.CrossRefPubMedGoogle Scholar
  88. 88.
    Saksena S, Clinical practice patterns in implantable rhythm management device therapy: New players and new norms, PACE 1999; 22: 814–815.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Paul A. Levine
    • 1
  • Dale M. Isaeff
    • 2
  1. 1.St. Jude Medical CenterSylmarUSA
  2. 2.Pacemaker Surveillance ProgramLoma Linda University Medical SchoolLoma LindaUSA

Personalised recommendations